{"id":"W4402560117","doi":"10.1016/j.annonc.2024.08.671","title":"604O Phase I dose escalation and initial dose expansion results of AMG 193: A MTA-cooperative PRMT5 inhibitor, in patients (pts) with MTAP-deleted solid tumors","year":2024,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Cancer-related gene regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":11,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Maximum tolerated dose; Pharmacology; Nuclear medicine; Adverse effect","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007114835,0.0009299575,0.001292683,0.0005723351,0.0003956278,0.0008109682,0.0005427317,0.00075746,0.002892457],"category_scores_gemma":[0.000586112,0.0003219963,0.0009566899,0.0004851394,0.000608954,0.0004554746,0.0002652968,0.002153473,0.0007064221],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008742411,"about_ca_system_score_gemma":0.001016989,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002331928,"about_ca_topic_score_gemma":0.003747211,"domain_scores_codex":[0.9997645,0.00007746399,0.00001185513,0.00003588441,0.00002246994,0.00008783539],"domain_scores_gemma":[0.9997631,0.00005348023,0.00002580479,0.00002688686,0.00001350789,0.0001172594],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.5230975,0.0686167,0.01730747,0.0005065706,0.00121375,0.000564172,0.0006006403,0.008393727,0.1621963,0.000711948,0.008518582,0.2082728],"study_design_scores_gemma":[0.2664717,0.6333154,0.04718119,0.00005029938,0.001052412,0.0007258686,0.0001646588,0.004816254,0.03623482,0.0005685695,0.009346971,0.00007176545],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9950475,0.0009373631,0.0003441063,0.0002894219,0.00007706035,0.0005612594,0.0009012766,0.00008499945,0.001757103],"genre_scores_gemma":[0.9916492,0.000916571,0.001260508,0.0003902155,0.00009285514,0.0006635789,0.002529949,0.00004346951,0.002453778],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002892457,"threshold_uncertainty_score":0.009676278,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02474736697317593,"score_gpt":0.3549713254129717,"score_spread":0.3302239584397957,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}